NASDAQ:SILO

Silo Pharma Earnings Date & Estimates

Silo Pharma logo
$1.67 +0.10 (+6.29%)
As of 10:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Silo Pharma is estimated to report earnings on Wednesday, December 2, 2026.

What Analysts Expect from Silo Pharma

Silo Pharma is expected to post earnings of -$4.80 per share on revenue of $18 thousand. In the same quarter a year earlier Silo Pharma reported -$1.80 per share on revenue of $18.03 thousand. Silo Pharma last reported on November 13, 2026, posting -$0.21 per share and beating the -$4.80 consensus estimate.

Consensus Estimates

Consensus EPS
-$4.80
Expected Revenue
$18 thousand
Prior-Year EPS
-$1.80
Prior-Year Revenue
$18.03 thousand
Expected Revenue Growth
-0.1%

Recent Track Record

Last Reported
Q3 2026
Last Quarter EPS
-$0.21 (Beat by +$4.59)

Silo Pharma Earnings FAQ

Silo Pharma (NASDAQ:SILO) is estimated to report earnings on Wednesday, December 2, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Silo Pharma to post earnings of -$4.80 per share for the quarter.

The consensus revenue estimate for Silo Pharma is $18 thousand for the quarter.

Silo Pharma Earnings Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Silo Pharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Silo Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Silo Pharma and other key companies, straight to your email.

About Silo Pharma

Silo Pharma (NASDAQ:SILO) is a development-stage biopharmaceutical company focused on treatments for central nervous system disorders and pain conditions. Its research programs include potential therapies for post-traumatic stress disorder, Alzheimer’s disease and chronic pain.

The company works on drug candidates and delivery approaches involving compounds such as ketamine, including formulations intended to support targeted or sustained treatment. Silo’s programs remain in development, and the company does not have a marketed product.

View Silo Pharma Profile